RNA emerges from DNA's shadow

RNA, the transporter of genetic information within the cell, has emerged from the shadow of DNA to become one of the hottest research areas of molecular biology, with implications for many diseases as well as understanding of evolution. But the field is complex, requiring access to the latest equipment and techniques of imaging, gene expression analysis and bioinformatics, as well as cross-pollination between multiple scientific disciplines. This has led to a major European push to bring the field together via a network of overlapping multidisciplinary projects, spearheaded by the European Science Foundation (ESF) with its EUROCORES Programme RNAQuality.

The great potential of the RNA research field to solve a variety of fundamental problems relevant for understanding of life and predicting cures for diseases was unleashed at the RNAQuality Programme's first conference, held in Granada in June 2008. As well as many European groups, the conference was represented by leading pioneers from the US in the field, who welcomed the new initiative as an important collaborative force.

RNA was once considered to be just the faithful messenger taking genetic information from the genome to the ribosome, or protein factory, but that view has been blown away by recent research. It is now known that RNA has additional roles in regulating gene expression and as an important structural component both in the cell nucleus and in the ribosomes. Furthermore, errors in transcribing RNA from DNA are frequent and require a variety of elaborate quality control mechanisms to prevent both mis-regulation of genes, and manufacture of aberrant RNA and protein fragments that clog up the workings of the cell, and that if unchecked can cause a variety of disorders, including cancers.

Delegates at the conference also heard how there is great potential for creating new compounds that manipulate the cell's apparatus for transcribing DNA into RNA to overcome a number of serious disorders caused by deleterious mutations in specific genes, as opposed to problems with the RNA itself. Jacobson also presented one of the most exciting developments, a molecule that overcomes a common deficiency in genes that prevents their being read right up to the end of their sequence during transcription.

Jacobson pointed out that there are about 2400 human genetic disorders resulting from mutations that cause genes to be incompletely read, including cystic fibrosis and muscular dystrophy. A drug based on the molecule is now entering trials that could lead to it becoming generally available. Results so far indicate dramatic improvements in both cystic fibrosis and muscular dystrophy sufferers, although it is only suitable for those disorders caused by the presence of a premature stop sign in a gene sequence, as a result of a mutation. It does though highlight the huge therapeutic potential of the research into RNA and its quality control.

Significant progress has been made in different aspects of RNA research over the last decade or more, leading to the current situation where many groups are working on different aspects of the problem. The challenge being met by the ESF's RNAQuality Programme is to bring these groups together, and make Europe a much greater force in the field, according to Jim Anderson, from Marquette University's Department of Biological Sciences in the US.

Another important aspect of RNA research lies in the interaction between DNA transcription, and the physical structure both of the membrane-bound cell nucleus and the genome coiled within it. Genes are transcribed within the nucleus and the resulting RNA molecules then emerge through small holes that are connected to the genome by proteins called nuclear pore complexes. In one of the presentations, Nick Proudfoot from Oxford University in the UK explained how some genes are enhanced by being close to the nuclear pore complex, indicating a close relationship between gene expression and nuclear structure that must have played out through evolutionary history. Another point to emerge from Proudfoot's presentation was how some genes are expressed more efficiently for a different reason, because the section of DNA containing their sequence is coiled locally into a loop, rather than as a branch.

Quite simply, this speeds up the transcription process of reading the gene because the enzyme concerned, RNA Polymerase, can just keep on encircling the loop. As Proudfoot explained, this is relevant for quality control as well. "They may afford quality control by "telling" the polymerase it is transcribing a bona fide gene, with a proper beginning and end," said Proudfoot. "Otherwise the polymerase may have initiated erroneously." The existence of a DNA ring makes it easier to identify the sequence corresponding to a gene, and transcribe it correctly.

Source: European Science Foundation

Related stories:

Accumulated bits of a cell's own DNA can trigger autoimmune disease
A security system wired within every cell to detect the presence of rogue viral DNA can sometimes go awry, triggering an autoimmune response to single-stranded bits of the cell's own DNA, according to a report in the August 22nd issue of the journal Cell, a Cell Press publication. The source of that single-stranded DNA is so-called endogenous retroelements—genetic elements accounting for a substantial portion of the genome that can move to new locations using a "copy and paste" mechanism, according to the researchers.
Scientists identify single microRNA that controls blood vessel development
Scientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues and organs. The research, published in the latest issue of Developmental Cell, may offer clues to potential therapeutic targets for a wide variety of diseases, such as heart disease or cancer, that are impacted by or affect the vascular system.
'Silencing' HIV with small bits of RNA
Researchers have shown that they can effectively tackle HIV-1 with small bits of gene-silencing RNA by delivering them directly to infected T cells, the major targets of the virus. While earlier studies had shown such a strategy could fight against many viruses including HIV-1, the new study in mice with human blood cells, so-called humanized mice, is the first to demonstrate an effective approach to systemic delivery in a living animal.
Putting microRNAs on the stem cell map
Embryonic stem cells are always facing a choice—either to self-renew or begin morphing into another type of cell altogether. It's a tricky choice, governed by complex gene regulatory circuitry driven by a handful of key regulators known as "master transcription factors," proteins that switch gene expression on or off.
New Yeast Trick for Eating Favorite Food
It is well known that yeast, the humble ingredient that goes into our breads and beers, prefer to eat some sugars more than others. Glucose, their favorite food, provides more energy than any other sugar, and yeast has evolved a complex genetic network to ensure that they consume as much glucose as possible whenever it is available. UC San Diego bioengineers have recently identified a previously unknown mechanism that allows yeast to shut down the metabolism of another sugar, galactose, when they sense glucose in the environment.
A new biomarker for early cancer detection? Research reveals that 'microRNA' may fit the bill
Scientists at Fred Hutchinson Cancer Research Center have discovered that microRNAs – molecular workhorses that regulate gene expression – are released by cancer cells and circulate in the blood, which gives them the potential to become a new class of biomarkers to detect cancer at its earliest stages. Muneesh Tewari, M.D., Ph.D., and colleagues describe their findings in the July 28 issue of the Proceedings of the National Academy of Sciences.
Researchers Discover Remnant of an Ancient 'RNA World'
(PhysOrg.com) -- Some bacterial cells can swim, morph into new forms and even become dangerously virulent - all without initial involvement of DNA. Yale University researchers describe Friday in the journal Science how bacteria accomplish this amazing feat - and in doing so provide a glimpse of what the earliest forms of life on Earth may have looked like.
A new look at how genes unfold to enable their expression
(PhysOrg.com) -- Cornell researchers have uncovered surprising new information about the process by which genes are unwrapped and exposed so that they can be expressed.

News discussion:

General Science news